A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

Clinical trial NCT02601950 · COMPLETED

Trial details

NCT number: NCT02601950
Sponsor: Epizyme, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Rhabdoid Tumors (MRT)Rhabdoid Tumors of the Kidney (RTK)Atypical Teratoid Rhabdoid Tumors (ATRT)Selected Tumors With Rhabdoid Features Synovial Sarcoma INI1-negative Tumors Malignant Rhabdoid Tumor of Ovary Renal Medullary Carcinoma Epithelioid Sarcoma Poorly Differentiated Chordoma (or Other Chordoma With Sponsor Approval)Any Solid Tumor With an EZH2 GOF Mutation

Start date: 2015-12-22
Primary completion: 2024-02-26
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.